Intrinsic Value of S&P & Nasdaq Contact Us

China SXT Pharmaceuticals, Inc. SXTC NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score
28/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — SXTC

China SXT Pharmaceuticals, Inc. (SXTC) has a market capitalization of $1.59M and trades at $1.86. The 52-week range is 1.25-1047.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-8.18, annual revenue of $1.74M.

The stock has a beta of 1.75, operates in the Healthcare sector.

Trading Data
Current Price$1.86
52-Week Range1.25-1047
Volume44.88K
Avg Volume (30D)279.05K
Market Cap$1.59M
Beta (1Y)1.75
Company
IPO Date2019-01-04
Employees75
CEOFeng Zhou
CountryCN
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINVGG2161P1650
CUSIPG2161P165
Income (Latest Year)
Revenue$1.74M
Gross Profit$367.43K
EBITDA$-2.57M
Operating Income$-2.68M
Net Income$-3.3M
EPS$-8.18
EPS Diluted$-8.18
Shares Outstanding$403.92K
Balance Sheet (Latest Year)
Total Assets$21.66M
Current Assets$21.3M
Cash & ST Investments$18.1M
Total Liabilities$6.22M
Total Debt$983.88K
Net Debt$-17.12M
Total Equity$15.44M
Debt / Equity0.06
Valuation Ratios
P/E Ratio-0.2
P/S Ratio0.91
P/B Ratio0.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message